Previous Article | Next Article 
Applied and Environmental Microbiology, February 2008, p. 912-915, Vol. 74, No. 3
0099-2240/08/$08.00+0 doi:10.1128/AEM.01655-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Heterologous Expression of the Pneumococcal Serotype 14 Polysaccharide in Lactococcus lactis Requires Lactococcal epsABC Regulatory Genes
,
Masja N. Nierop Groot,
Jeroen Godefrooij, and
Michiel Kleerebezem*
TI Food and Nutrition, NIZO food research, Kernhemseweg 2, P.O. Box 20, 6710 BA Ede, The Netherlands
Received 19 July 2007/
Accepted 2 December 2007

ABSTRACT
The pneumococcal serotype 14 polysaccharide was produced in
Lactococcus lactis by coexpressing pneumococcal polysaccharide
type 14-specific genes (
cpsFGHIJKL14) with the lactococcal regulatory
and priming glucosyltransferase-encoding genes specific for
B40 polysaccharide (
epsABCDB40). The polysaccharide produced
by
Lactococcus was secreted in the medium, simplifying downstream
processing and polysaccharide isolation from culture broth.

INTRODUCTION
Capsular polysaccharides (CPSs), either as purified polysaccharides
or as protein conjugates thereof (
19), have been applied as
antigens in several vaccines that are currently marketed. Pneumococci
are a common cause of respiratory tract infections (pneumonia)
and ear infections (otitis media) but can also cause more life-threatening
diseases like meningitis and sepsis (
12,
13). Heterologous expression
of pneumococcal CPS in nonpathogenic
Lactococcus lactis has
significant advantages relative to the current pneumococcal
production process, including the reduced biological containment
requirements for
L. lactis. In addition, a
L. lactis-based production
process is relatively easy to scale up to industrial volumes
by using low-cost cultivation conditions based on anaerobic
growth and relatively simple medium (Pharma Grade) (
9). A third
advantage of an
L. lactis-based production system could be that
the polysaccharide is devoid of C polysaccharide, a common impurity
in pneumococcus-derived material that is a highly reactive immunogen
resulting in an undesired antibody response (
5). Previously,
it has been shown that
L. lactis can produce pneumococcal serotype
3 polysaccharide (
3). In contrast, most other known serotypes
(
2) are synthesized by a relatively simple mechanism. Here we
chose serotype 14 as a model for a complex polysaccharide for
which biosynthesis occurs via the formation of lipid-linked
repeat units prior to their polymerization and export to form
capsular polysaccharides.
For the expression of type 14 polysaccharide (PS14) in L. lactis, the conserved cassette-like organization of polysaccharide biosynthesis gene clusters in bacteria is exploited in a combinatorial, cassette-based composite expression approach, in which gene cluster-specific regulatory and polysaccharide synthesis cassettes can be exchanged and expressed independently (Fig. 1; see the supplemental material).
Polysaccharides were determined by size exclusion chromatography
combined with multiangle light scattering as described previously
(
14) and by immunodetection with PS
14-specific antiserum obtained
from the Statens Serum Institute in Denmark. Nisin-induced cells
(
4) of
L. lactis harboring pNZ4230 carrying pneumococcal polysaccharide
serotype 14-specific genes (
cpsFGHIJKL14) and pNZ4205 carrying
polysaccharide B40-specific genes (
epsABCDB40) produced 25 mg/liter
polysaccharide recognized by serotype 14 antibodies (Table
1),
which is approximately 25% of the level of B40 polysaccharide
produced by
L. lactis harboring pNZ4220 (
epsEFGHIJKLB40) and
pNZ4205 (
epsABCDB40). Notably, no polysaccharide was produced
by the
L. lactis strain harboring the pneumococcal
cpsBCDE14 (pNZ4237) genes (Table
1) in combination with pNZ4230 (
cpsFGHIJKL14),
while
cpsBCDE14 (pNZ4237) could promote B40 polysaccharide (PS
B40)
biosynthesis (Table
1) in
L. lactis harboring pNZ4220 (EPS
B40-specific
gene cassette).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Polysaccharide isolated from the culture supernatant of L. lactis strains harboring eps and cps gene cassettes
|
The PS
14 produced in
L. lactis displayed a relatively monodisperse
mass range (polydispersity index [
Mw/
Mn], 1.39) that is typically
seen in lactococcal polysaccharides (
17) and centered around
a mass of 3.1
x 10
5 Da. The size of the serotype 14 polysaccharide
is comparable to the size of the extracellular polysaccharide
B40 (EPS
B40) (3.3
x 10
5 Da) produced in
L. lactis (pNZ4220 and
pNZ4205) and is in the same order of magnitude as the commercially
available serotype 14 polysaccharide (measured size, 8.6
x 10
5 Da) that was purchased from the ATCC (American Type Culture
Collection, Manassas, VA; ATCC number 197-x). This parameter
is relevant since polysaccharide length has been shown to affect
immunogenicity, and increased antibody titers against PS
14 were
reported for rabbit models by using polysaccharide conjugates
of higher molecular weights (
6). Polymer size in
L. lactis is
influenced by medium components (
8), which suggests that an
adjustment in medium composition can be exploited to eventually
optimize the immunogenicity of the PS
14 produced by
L. lactis.
Interestingly, immunodetection using serotype 14-specific antiserum revealed that the vast majority of the type 14-specific signal was found in the supernatant rather than attached to the cells (data not shown), suggesting that PS14 is released in the culture supernatant by L. lactis, which is in contrast to the case with its native production host (Streptococcus pneumoniae), wherein most polysaccharide is covalently linked to the cell wall (16). This finding could simplify downstream processing aiming to isolate the polysaccharide from culture broth and avoids undesired contaminations when L. lactis is used as production host.
We have previously demonstrated that the phosphorylation of EpsBB40 in L. lactis prevents or strongly reduces EPS biosynthesis (14). Contrary to this result, in S. pneumoniae a strong phosphotyrosine-specific CpsD signal was always observed in wild-type cells that produced maximum CPS levels (1, 10, 11). A phosphotyrosine-specific signal was detected in L. lactis harboring the PS14-specific genes (pNZ4230) in combination with pNZ4237 (cpsBCDE14) (Fig. 2, lane 3), but not in combination with pNZ4205 (epsABCDB40) (Fig. 2, lane 1), which is in agreement with the reported production-stimulatory role of the unphosphorylated form of these regulatory proteins in L. lactis (14). A regulatory gene cassette lacking the predicted tyrosine phosphatase-encoding gene in the epsABCDB40 cassette (
epsCB40) (Fig. 1) was constructed (pNZ4208 [14]). No tyrosine-phosphate signal was detected in PS14-producing L. lactis expressing the epsABDB40 genes (Fig. 2, lane 2), indicating that even in the absence of the phosphatase (EpsC), the EpsB in these cells is present in its unphosphorylated form. In addition, this strain still produced PS14 at a level that was comparable to that produced in the strain coexpressing epsABCDB40 (25 and 21 mg/ml for the epsABCDB40 and the epsABDB40 constructs, respectively), which was secreted in the medium, thereby excluding the possibility that the deletion of epsC affects the subcellular location of the polysaccharide produced in L. lactis, as demonstrated previously for S. pneumoniae (11). These findings support previous data that indicate that polysaccharide biosynthesis in L. lactis is stimulated by the unphosphorylated form of these tyrosine-containing regulatory proteins and suggest a pivotal role of host-specific protein phosphorylation status in polysaccharide production control.
To further establish the identity of the serotype 14 polysaccharide
produced in
L. lactis, comparative proton-nuclear magnetic resonance
(NMR) analysis was performed with the polysaccharides isolated
from the
L. lactis culture and a commercially available, serotype
14 polysaccharide purified from
S. pneumoniae (ATCC). To this
end, the polysaccharide-containing solutions were fractionated
by size exclusion chromatography as described previously (
14)
and PS
14-containing fractions were collected, dialyzed against
Millipore water, and lyophilized. Lyophilized samples were dissolved
in 99.9% D
2O, and NMR spectra were taken at 400 MHz. The proton-NMR
spectra obtained with the PS
14 produced in
L. lactis and the
ATCC product appeared to be virtually identical (Fig.
3). The
minute variation in the two spectra is due to a small impurity
present in the PS
14 isolated from
S. pneumoniae; this impurity
resulted in an additional peak at 3.27 ppm that could not be
assigned to any moiety of the published repeating unit (
7).
These data, combined with the immunodetection data, indicate
the chemical identity of the repeating unit present in the polymer
produced in
L. lactis and that of the native production host,
S. pneumoniae.
S. pneumoniae CPS production levels reported in the literature
are 0.5 mg/10
9 CFU (serotype 19F [10]) and 0.6 mg/10
9 CFU (serotype
15B [
15]). The PS
14 level produced in
L. lactis was estimated
to be 0.15 mg/10
9 CFU (corresponds to 25 mg/liter), which is
in the same order of magnitude as the reported values for serotype
19F and serotype 15B in
S. pneumoniae. It should be noted that
L. lactis was grown in batch cultures without pH control or
optimization of fermentation to increase biomass yields. Therefore,
improved
L. lactis cultivation conditions most likely will allow
a further increase of polysaccharide production yields relative
to those described here.
Overall, L. lactis appears to be an attractive, alternative, heterologous production host for polysaccharides of pneumococcal origin but could possibly also be exploited for the production of polysaccharides derived from other gram-positive pathogens. The strategy employed here indicates that maintaining host-derived production control functions allows the overruling of regulatory constraints that might result from the transfer of polysaccharide production and its control from one host to the next.

ACKNOWLEDGMENTS
We thank Saskia van Selm and Jos van Putten (Department of Infectious
Diseases and Immunology, Utrecht University, Utrecht, The Netherlands)
for kindly providing
S. pneumoniae serotype 14 chromosomal DNA
and serotype 14-specific antiserum.
This work was supported by the European Commission through contract QLK1-CT-2000-01376 (Nutracells).

FOOTNOTES
* Corresponding author. Mailing address: NIZO food research, Kernhemseweg 2, P.O. Box 20, 6710 BA Ede, The Netherlands. Phone: 31-318-659629. Fax: 31-318-650400. E-mail:
Michiel.Kleerebezem{at}nizo.nl 
Published ahead of print on 14 December 2007. 
Supplemental material for this article may be found at http://aem.asm.org/. 
Present address: TI Food and Nutrition, Bornsesteeg 59, P.O. Box 17, 6700 AA Wageningen, The Netherlands. 

REFERENCES
1 - Bender, M. H., R. T. Cartee, and J. Yother. 2003. Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. J. Bacteriol. 185:6057-6066.[Abstract/Free Full Text]
2 - Bentley, S. D., D. M. Aanensen, A. Mavroidi, D. Saunders, E. Rabbinowitsch, M. Collins, K. Donohoe, D. Harris, L. Murphy, M. A. Quail, G. Samuel, I. C. Skovsted, M. S. Kaltoft, B. Barrell, P. R. Reeves, J. Parkhill, and B. G. Spratt. 2006. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2:e31.[CrossRef][Medline]
3 - Gilbert, C., K. Robinson, R. W. F. Le Page, and J. M. Wells. 2000. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect. Immun. 68:3251-3260.[Abstract/Free Full Text]
4 - Kuipers, O. P., P. G. G. A. De Ruyter, M. Kleerebezem, and W. M. De Vos. 1998. Quorum sensing-controlled gene expression in lactic acid bacteria. J. Biotechnol. 64:15-21.[CrossRef]
5 - Laferriere, C. A., R. K. Sood, J. M. de Muys, F. Michon, and H. J. Jennings. 1997. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity. Vaccine 15:179-186.[CrossRef][Medline]
6 - Laferriere, C. A., R. K. Sood, J. M. de Muys, F. Michon, and H. J. Jennings. 1998. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes. Infect. Immun. 66:2441-2446.[Abstract/Free Full Text]
7 - Lindberg, B., J. Lonngren, and D. A. Powell. 1977. Structural studies on the specific type-14 pneumococcal polysaccharide. Carbohydr. Res. 58:177-186.[CrossRef][Medline]
8 - Looijesteijn, P. J., W. H. van Casteren, R. Tuinier, C. H. Doeswijk-Voragen, and J. Hugenholtz. 2000. Influence of different substrate limitations on the yield, composition and molecular mass of exopolysaccharides produced by Lactococcus lactis subsp. cremoris in continuous cultures. J. Appl. Microbiol. 89:116-122.[CrossRef][Medline]
9 - Mierau, I., and M. Kleerebezem. 2005. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl. Microbiol. Biotechnol. 68:705-717.[CrossRef][Medline]
10 - Morona, J. K., R. Morona, D. C. Miller, and J. C. Paton. 2003. Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. J. Bacteriol. 185:3009-3019.[Abstract/Free Full Text]
11 - Morona, J. K., R. Morona, and J. C. Paton. 2006. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proc. Natl. Acad. Sci. USA 103:8505-8510.[Abstract/Free Full Text]
12 - Mulholland, K. 1999. Strategies for the control of pneumococcal diseases. Vaccine 17(Suppl. 1):S79-S84.[CrossRef][Medline]
13 - Musher, D. M. 1992. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-807.[Medline]
14 - Nierop Groot, M. N., and M. Kleerebezem. Mutational analysis of the Lactococcus lactis NIZO B40 exopolysaccharide gene cluster: EPS biosynthesis correlates with unphosphorylated EpsB. J. Appl. Microbiol., in press.
15 - Selm, V. S. 2003. Generation of capsule diversity in Streptococcus pneumoniae. Ph.D. thesis. Utrecht University, Utrecht, The Netherlands.
16 - Sørensen, U. B., J. Henrichsen, H. C. Chen, and S. C. Szu. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8:325-334.[CrossRef][Medline]
17 - Tuinier, R., W. H. van Casteren, P. J. Looijesteijn, H. A. Schols, A. G. Voragen, and P. Zoon. 2001. Effects of structural modifications on some physical characteristics of exopolysaccharides from Lactococcus lactis. Biopolymers 59:160-166.[CrossRef][Medline]
18 - Vos, P., M. van Asseldonk, F. van Jeveren, R. Siezen, G. Simons, and W. M. de Vos. 1989. A maturation protein is essential for production of active forms of Lactococcus lactis SK11 serine proteinase located in or secreted from the cell envelope. J. Bacteriol. 171:2795-2802.[Abstract/Free Full Text]
19 - Weintraub, A. 2003. Immunology of bacterial polysaccharide antigens. Carbohydr. Res. 338:2539-2547.[CrossRef][Medline]
Applied and Environmental Microbiology, February 2008, p. 912-915, Vol. 74, No. 3
0099-2240/08/$08.00+0 doi:10.1128/AEM.01655-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.